Clinical trials: Post ERCP Pancreatitis
ERCP, Biliary Disease Tract
Is Needle Knife Fistulotomy An Effective First Step Strategy For All ERCPs?
Participants in this study will be undergoing a procedure called an endoscopic retrograde cholangiopancreatography (ERCP). This procedure is most commonly performed to help treat conditions affecting specific areas of the…
- Conditions
- ERCP, Biliary Disease Tract, Biliary Disease
- Trial name
- NCT03698266
- Testing
- Needle knife fistulotomy
- Where
- Canada
- Volunteers
- 84 people
- Sponsor
- Lawrence Charles Hookey
Post-ERCP Acute Pancreatitis
Lactated Ringer's Solution to Prevent Post-ERCP Pancreatitis
This is a randomized, double-blinded, controlled trial. This study is a head to head comparison of normal saline (NS) infusion versus Lactated Ringer's (LR) infusion in patients, with the primary outcome of post-ERCP pancreatitis…
- Trial name
- NCT03215862
- Testing
- Lactated Ringer, Normal Saline 0.9% Infusion Solution Bag
- Volunteers
- 242 people
- Sponsor
- University of South Florida
Acute Biliary Pancreatitis
Prophylactic Sphincterotomy in Acute Biliary Pancreatitis Patients Unfit for Surgery
This is a prospective, multicenter, open-label, randomized controlled trial designed to evaluate the efficacy and safety of prophylactic endoscopic sphincterotomy (ES) in frail patients unfit for cholecystectomy following an…
- Trial name
- PROSECCO (NCT07238296)
- Testing
- Prophylactic endoscopic sphincterotomy
- Volunteers
- 92 people
- Sponsor
- Semmelweis University
Post-ERCP Acute Pancreatitis
Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic Pancreatitis
The purpose of this study is to compare the incidence of post-ERCP pancreatitis (PEP) in chronic pancreatitis (CP) patients to that in biliary disease patients, to determine whether CP patients in early clinical stage have a…
- Trial name
- NCT02781987
- Testing
- chronic pancreatitis
- Volunteers
- 2,028 people
- Sponsor
- Changhai Hospital
Post ERCP Acute Pancreatitis
Indomethacin Decreases Post-ERCP Pancreatitis
Endoscopic retrograde cholangiopancreatography (ERCP) is now a widely accepted therapy for treating benign and malignant diseases of the pancreatobiliary tree.
- Trial name
- Indomethacin (NCT02110810)
- Testing
- Indomethacin, 2.6-g suppository of glycerin
- Where
- Mexico
- Volunteers
- 160 people
- Sponsor
- Instituto Mexicano del Seguro Social
Cholangiopancreatography, Endoscopic Retrograde, Pancreatitis
Tailored Hydration for the Prevention of Post-ERCP Pancreatitis
Aggressive hydration of lactated Ringer's solution has shown considerable beneficial effect in preventing post-ERCP(endoscopic retrograde cholangiopancreatography) pancreatitis.
- Trial name
- NCT03561441
- Testing
- Tailored aggressive hydration, Tailored standard hydration
- Where
- South Korea
- Volunteers
- 350 people
- Sponsor
- Chonnam National University Hospital
Pancreatic Diseases
Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Endoscopic retrograde cholangiopancreatography (ERCP (, a key tool that is used in diagnosis and treatment of pancreato-biliary diseases.
- Trial name
- NCT06861010
- Testing
- Ondansetron
- Where
- Egypt
- Volunteers
- 44 people
- Sponsor
- Tanta University
Pancreatitis, Chronic
Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.
This study aims to determine the optimal timing of endoscopic intervention after extracorporeal shock wave lithotripsy(ESWL) of chronic pancreatitis with pancreatic stones.
- Trial name
- TEST (NCT05270434)
- Testing
- time interval between ESWL and ERCP is 12h, time interval between ESWL and ERCP is greater than 12h, morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics)
- Where
- China
- Volunteers
- 220 people
- Sponsor
- Changhai Hospital
Acute Pancreatitis
Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)
To determine if the timing of administration of indomethacin affects the primary outcome of post-ERCP pancreatitis (PEP). Patients undergoing ERCP will be randomly assigned to receive pre or post-procedure rectal indomethacin to…
- Trial name
- NCT02111707
- Testing
- Rectal indomethacin 100mg one time before or after ERCP
- Where
- Canada
- Volunteers
- 534 people
- Sponsor
- University of Alberta
Post-ERCP Acute Pancreatitis
IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis
Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced endoscopic technique utilized to diagnose and treat pathologic conditions involving the ducts draining the liver and pancreas.
- Trial name
- NCT02241512
- Testing
- Ibuprofen
- Where
- United States
- Volunteers
- 69 people
- Sponsor
- University of Texas Southwestern Medical Center
Pancreatitis
A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis
Determine if IV ketorolac is an effective agent in the prevention of post-ERCP pancreatitis. Determine if IV ketorolac provides improved post-procedure analgesia.
- Trial name
- NCT02465138
- Testing
- Ketorolac
- Where
- 2 sites in United States
- Sponsor
- University of California, San Francisco
Post-ERCP Acute Pancreatitis
Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers
Octreotide, somatostatin and pentoxyfilline commercially available drugs that are used in various clinical situations. They are safe and known for years.
- Trial name
- NCT00222092
- Where
- Greece
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- University of Ioannina
Biliary Disease
Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Endoscopic retrograde cholangiopancreatography (ERCP (, a key tool that is used in diagnosis and treatment of pancreato-biliary diseases.
- Trial name
- NCT06860984
- Testing
- Duloxetine
- Where
- Egypt
- Volunteers
- 44 people
- Sponsor
- Tanta University
Abdominal Pain, Post-ERCP Acute Pancreatitis
A Trial of 0.025 Wire Guided Cannulation Versus Current Practice 0.035 Wire Guided Cannulation
The aim of this study is to determine whether using a smaller wire results in a higher success rate at endoscopic retrograde cholangiopancreatography (ERCP), and lower incidence of adverse events
- Trial name
- NCT01408264
- Testing
- Conventional 0.035 guidewire, Olympus Visiglide 0.025 guidewire
- Where
- China
- Volunteers
- 184 people
- Sponsor
- Chinese University of Hong Kong
Post-ERCP Pancreatitis, Pancreatitis, Acute Necrotizing
The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis
With the development of endoscopic technology, ERCP has been widely used in the diagnosis and treatment of pancreatobiliary diseases, and has become the first treatment for most of the biliary and pancreatic diseases.
- Trial name
- NCT03643900
- Testing
- pancreatic duct stenting, rectal indomethacin
- Where
- China
- Volunteers
- 618 people
- Sponsor
- First People's Hospital of Hangzhou
Pancreatitis
Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis
Endoscopic retrograde cholangiopancreatography (ERCP) is a technically demanding procedure combining endoscopy and fluoroscopy to diagnose and treat pancreaticobiliary disorders such as bile duct stones, strictures, and…
- Trial name
- NCT07083063
- Testing
- Nitroglycerin (NTG), Normal Saline (0.9% NaCl)
- Where
- Taiwan
- Volunteers
- 440 people, healthy volunteers welcome
- Sponsor
- National Cheng-Kung University Hospital
Pancreatitis, ERCP
Prophylaxis Against Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis.
Endoscopic retrograde cholangiopancreatography (ERCP) is a key procedure for managing biliopancreatic diseases, although it is associated with complications such as post-ERCP pancreatitis.
- Trial name
- Post-ERCP (NCT07599605)
- Testing
- Rectal Indometacin
- Where
- Mexico
- Volunteers
- 60 people
- Sponsor
- Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
Pancreatitis
Post ERCP Pancreatitis Prevention in Average Risk Patients
Diclophenac potassium and ceftazidime are commercially available drugs that are used in various clinical situations. They are safe and known for years.
- Trial name
- NCT01784445
- Testing
- Ceftazidime
- Where
- Croatia
- Volunteers
- 124 people
- Sponsor
- University Hospital Rijeka
Endoscopic Retrograde Cholangiopancreatography
Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?
The purpose of the study is to compare the risk of PEP after pancreatic sphincterotomy performed for difficult cannulation in a group of patients with and in a group of patients without placement of a prophylactic pancreatic…
- Trial name
- NCT04408482
- Testing
- Biliary cannulation
- Where
- Finland
- Volunteers
- 268 people
- Sponsor
- Helsinki University Central Hospital
Pancreatitis
A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
The purpose of this study is to determine if giving Aprepitant 4 hours before and for two days after ERCP decreases the risk of developing pancreatitis after ERCP.
- Trial name
- NCT00736073
- Testing
- aprepitant
- Where
- United States
- Volunteers
- 73 people
- Sponsor
- Duke University